The introduction of troglitazone, a potent insulin-sensitizing agent, marked a significant chapter in the management of type 2 diabetes. However, its withdrawal from the market due to serious hepatotoxicity spurred https://cyrusrqzy091483.blogdigy.com/troglityzone-and-related-glitazones-a-relative-overview-64891510